Probiotics LGGBB12 or RC14GR1 versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury ProSCIUTTU a randomised controlled trial

Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial

12:30 EST 27 Feb 2019 | Nature Publishing

More From BioPortfolio on "Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial"